Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    mo22097
Show Display Options
Rank Status Study
1 Completed A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Condition: Non-Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: Docetaxel;   Drug: Erlotinib;   Drug: Pemetrexed

Indicates status has not been verified in more than two years